Tumor-informed assessment of molecular residual disease and its incorporation into practice for patients with early and advanced-stage colorectal cancer (CRC-MRD Consortia).
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Pashtoon Murtaza Kasi, Farshid Dayyani, Van K. Morris, Scott Kopetz, Aparna Raj Parikh, Jason Scott Starr, Stacey Cohen, Axel Grothey, Christopher Hanyoung Lieu, Mark H. O'Hara, Kate Loranger, Laura Westbrook, Shruti Sharma, Shifra Krinshpun, Nicole Hook, Bernhard Zimmermann, Paul R. Billings, Alexey Aleshin
Institutions: Mayo Clinic in Florida, University of California, Irvine, The University of Texas MD Anderson Cancer Center, Massachusetts General Hospital, University of Washington, West Cancer Center, University of Colorado Cancer Center, Abramson Cancer Center, University of Pennsylvania, Natera (United States)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3031421676